Bernard Coulie is President, Chief Executive Officer and Director of Pliant Therapeutics, Inc. (PLRX). The company reported total compensation of $5,462,901 for fiscal year 2025.
| Salary | $682,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $1,810,250 |
| Option awards | $2,713,750 |
| Non-equity incentive plan | $204,600 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $52,301 |
| Total | $5,462,901 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Pliant Therapeutics, Inc. filed April 22, 2026, accession 0001746473-26-000076.
| Peer-group chief executive median | $6,323,117 |
|---|---|
| Difference from that median | $-860,216 |
| Percentile within the disclosed peer group | 41st |
| Peers with a disclosed figure | 21 |
Medians and percentiles are computed across the peer group Pliant Therapeutics, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Bernard Coulie this page | President, Chief Executive Officer and Director | $5,462,901 |
| Eric Lefebvre | Former Chief Medical Officer | $2,724,860 |
| Keith Cummings | Chief Financial Officer | $2,397,337 |
| Minnie Kuo | Chief Operating Officer | $1,542,854 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Pliant Therapeutics, Inc. compensation brief.
Bernard Coulie's compensation sits inside Pliant Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.